Lars Forsgren

7.0k total citations · 1 hit paper
101 papers, 4.9k citations indexed

About

Lars Forsgren is a scholar working on Neurology, Physiology and Molecular Biology. According to data from OpenAlex, Lars Forsgren has authored 101 papers receiving a total of 4.9k indexed citations (citations by other indexed papers that have themselves been cited), including 73 papers in Neurology, 24 papers in Physiology and 20 papers in Molecular Biology. Recurrent topics in Lars Forsgren's work include Parkinson's Disease Mechanisms and Treatments (70 papers), Neurological disorders and treatments (34 papers) and Neurological diseases and metabolism (11 papers). Lars Forsgren is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (70 papers), Neurological disorders and treatments (34 papers) and Neurological diseases and metabolism (11 papers). Lars Forsgren collaborates with scholars based in Sweden, United Kingdom and United States. Lars Forsgren's co-authors include Jan Linder, Magnus Domellöf, Henrik Zetterberg, Kaj Blennow, Eva Elgh, Peter M. Andersen, Susanna Jakobson Mo, Katrine Riklund, Marwan Hariz and Stefan L. Marklund and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Genetics and SHILAP Revista de lepidopterología.

In The Last Decade

Lars Forsgren

100 papers receiving 4.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Blood-based NfL

2017 356 citations Oskar Hansson, Shorena Janelidze et al. Neurology profile →

Peers

Countries citing papers authored by Lars Forsgren

Since Specialization

Citations

This map shows the geographic impact of Lars Forsgren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lars Forsgren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lars Forsgren more than expected).

Fields of papers citing papers by Lars Forsgren

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lars Forsgren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lars Forsgren. The network helps show where Lars Forsgren may publish in the future.

Co-authorship network of co-authors of Lars Forsgren

This figure shows the co-authorship network connecting the top 25 collaborators of Lars Forsgren. A scholar is included among the top collaborators of Lars Forsgren based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lars Forsgren. Lars Forsgren is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Prediction and early biomarkers of cognitive decline in Parkinson disease and atypical parkinsonism: a population-based study 2022 ·Brain Communications ·David Bäckström, Gabriel Granåsen, Susanna Jakobson Mo, Katrine Riklund, Miles Trupp, Henrik Zetterberg, Kaj Blennow, Lars Forsgren, Magnus Domellöf	24
2	Lack of Association Between GBA Mutations and Motor Complications in European and American Parkinson's Disease Cohorts 2021 ·Duo Research Archive (University of Oslo) ·Jodi Maple‐Grødem, Kimberly C. Paul, Ingvild Dalen, Kathie J. Ngo, Darice Y. Wong, Angus D. Macleod, Carl Counsell, David Bäckström, Lars Forsgren, Ole‐Bjørn Tysnes, Cynthia Kusters, Brent L. Fogel, Jeff M. Bronstein, Beate Ritz, Guido Alves	5
3	Deep mining of oxysterols and cholestenoic acids in human plasma and cerebrospinal fluid: Quantification using isotope dilution mass spectrometry 2021 ·Analytica Chimica Acta ·Eylan Yutuc, (unknown), (unknown), (unknown), Paul R.S. Baker, (unknown), Anders Öhman, Lars Forsgren, Miles Trupp, Sílvia Vilarinho, (unknown), Peter T. Clayton, Sinan Sarı, Buket Dalgıç, (unknown), Lüdger Schöls, William J. Griffiths, Yuqin Wang	13
4	Association of SNCA Parkinson's Disease Risk Polymorphisms With Disease Progression in Newly Diagnosed Patients 2021 ·Frontiers in Neurology ·(unknown), (unknown), Anastasia Ushakova, Lars Forsgren, Ole‐Bjørn Tysnes, Carl Counsell, Guido Alves, Johannes Lange, Angus D. Macleod, Jodi Maple‐Grødem	8
5	Evaluating a frontostriatal working-memory updating-training paradigm in Parkinson’s disease: the iPARK trial, a double-blinded randomized controlled trial 2020 ·BMC Neurology ·(unknown), (unknown), Carl‐Johan Boraxbekk, David Bäckström, Maria Josefsson, Lars Forsgren, Anna Stigsdotter Neely	0
6	Targeted Multiple Reaction Monitoring Analysis of CSF Identifies UCHL1 and GPNMB as Candidate Biomarkers for ALS 2019 ·Journal of Molecular Neuroscience ·Shaochun Zhu, Anna Wuolikainen, Junfang Wu, Anders Öhman, Gunnar Wingsle, Thomas Möritz, Peter M. Andersen, Lars Forsgren, Miles Trupp	37
7	Combinatory microRNA serum signatures as classifiers of Parkinson's disease 2019 ·Parkinsonism & Related Disorders ·Ketan S. Patil, Indranil Basak, Ingvild Dalen, Esthelle Hoedt, Johannes Lange, (unknown), Ying Liu, Ole‐Bjørn Tysnes, Lars Forsgren, Dag Aarsland, Thomas A. Neubert, Jan Larsen, Guido Alves, Simon Geir Møller	28
8	Blood-based NfL breakdown → 2017 ·Neurology ·Oskar Hansson, Shorena Janelidze, Sara Hall, Nadia Magdalinou, Andrew J. Lees, Ulf Andréasson, Niklas Norgren, Jan Linder, Lars Forsgren, Radu Constantinescu, Henrik Zetterberg, Kaj Blennow, (unknown)	356
9	Moist smokeless tobacco (Snus) use and risk of Parkinson’s disease 2016 ·International Journal of Epidemiology ·Fei Yang, Nancy L. Pedersen, Weimin Ye, Zhiwei Liu, Margareta Norberg, Lars Forsgren, Ylva Trolle Lagerros, Rino Bellocco, Lars Alfredsson, Anders Knutsson, Jan‐Håkan Jansson, Patrik Wennberg, (unknown), Anton Lager, Marzieh Araghi, Michael Lundberg, Cecilia Magnusson, Karin Wirdefeldt	15
10	NMR metabonomics of cerebrospinal fluid distinguishes between Parkinson’s disease and controls 2015 ·Neuroscience Letters ·Anders Öhman, Lars Forsgren	56
11	Weight gain and increased central obesity in the early phase of Parkinson's disease 2014 ·Clinical Nutrition ·(unknown), Maine Carlsson, Jan Linder, Lars Forsgren, Lena Håglin	61
12	No GGGGCC-hexanucleotide repeat expansion inC9ORF72in parkinsonism patients in Sweden 2012 ·Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration ·Chizuru Akimoto, Lars Forsgren, Jan Linder, Anna Birve, (unknown), (unknown), (unknown), (unknown), Peter M. Andersen	20
13	Deep brain stimulation of the subthalamic nucleus versus the zona incerta in the treatment of essential tremor 2011 ·Acta Neurochirurgica ·Patric Blomstedt, Ulrika Sandvik, Jan Linder, (unknown), Lars Forsgren, Marwan Hariz	44
14	The relation between cognition and motor dysfunction in drug‐naive newly diagnosed patients with Parkinson's disease 2011 ·Movement Disorders ·Magnus Domellöf, Eva Elgh, Lars Forsgren	101
15	α-Synuclein Reactive Antibodies as Diagnostic Biomarkers in Blood Sera of Parkinson's Disease Patients 2011 ·PLoS ONE ·Kiran Yanamandra, M. A. Gruden, Vida Časaitė, Rolandas Meškys, Lars Forsgren, Ludmilla A. Morozova‐Roche	134
16	Pre- and postsynaptic dopamine SPECT in the early phase of idiopathic parkinsonism: a population-based study 2010 ·European Journal of Nuclear Medicine and Molecular Imaging ·Susanna Jakobson Mo, Jan Linder, Lars Forsgren, Anne Larsson, Lennart Johansson, Katrine Riklund	44
17	Development and testing of a self administered version of the Freezing of Gait Questionnaire 2010 ·BMC Neurology ·Maria H Nilsson, Gun‐Marie Hariz, Klas Wictorin, Michael Miller, Lars Forsgren, Peter Hagell	41
18	Activities of daily living and quality of life in persons with newly diagnosed Parkinson’s disease according to subtype of disease, and in comparison to healthy controls 2010 ·Acta Neurologica Scandinavica ·(unknown), Lars Forsgren	135
19	Degenerative changes were common in brain magnetic resonance imaging in patients with newly diagnosed Parkinson’s disease in a population-based cohort 2009 ·Journal of Neurology ·Jan Linder, Richard Birgander, (unknown), Katrine Riklund, (unknown), Mona Edström, Hans Stenlund, Lars Forsgren	15
20	Motor neuron disease in transgenic mice and a patient carrying the G127insTGGG CuZn-superoxide dismutase mutation 1999 ·The Society for Neuroscience Abstracts ·Stefan L. Marklund, Peter Nilsson, Anna K. Jönsson, Thomas Brännström, (unknown), P. M. Andersen, Lars Forsgren, Ole Gredal	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact